Effect of Obesity on Prostate-Specific Antigen, Prostate Volume, and International Prostate Symptom Score in Patients with Benign Prostatic Hyperplasia
- Effect of Obesity on Prostate-Specific Antigen, Prostate Volume, and International Prostate Symptom Score in Patients with Benign Prostatic Hyperplasia
- 문기학; 김종민[김종민]; 송필현; 김현태
- Analysis of variance; Body mass index; Prostatic hyperplasia; Analysis of variance; Body mass index; Prostatic hyperplasia
- Issue Date
- Korean Journal of Urology, v.52, no.6, pp.401 - 405
- Purpose: We examined the correlation between body mass index (BMI) as a marker of obesity and prostate-specific antigen (PSA), prostate volume (PV), and International Prostate Symptom Score (IPSS) in patients with benign prostatic hyperplasia (BPH).
Materials and Methods: From January 2008 to December 2008, we examined 258 patients diagnosed with BPH. Patients taking 5a-reductase inhibitors or those diagnosed with prostate cancer were excluded from this study. BPH was defined as PV≥25 ml and IPSS≥8. BMI (kg/m^2) was categorized into 4 groups as follows: BMI＜18.5 (underweight), BMI 18.5-23.0 (normal), BMI 23.0-27.5 (overweight), and BMI＞27.5 (obese). The relationships between PSA, PV, IPSS, and BMI were analyzed by correlation analysis and one-way ANOVA.
Results: The mean age of the patients was 65.19±9.13 years and their mean BMI was 23.7±4.4 kg/m^2. The mean PSA values of each BMI group were as follows: 3.42±1.53, 3.07±1.88, 2.74±1.75, and 2.60±1.44 ng/ml. The PSA value was lowest in the obese group. The correlation analysis showed a negative correlation between BMI and PSA (Pearson’s correlation coefficient=−0.142, p=0.023) and positive correlations between BMI and PV (Pearson’s correlation coefficient=0.32, p=0.001) and IPSS (Pearson’s correlation coefficient=0.470, p=0.02). These correlations were also confirmed by one-way ANOVA.
Conclusions: Patients with an elevated BMI tended to have lower PSA values, larger PVs, and a higher IPSS. We suggest that weight loss could be helpful for BPH symptom relief as well as for detection of coexisting prostate cancer in BPH patients.
- Appears in Collections:
- 의과대학 > 비뇨기과학교실 > Articles
- Files in This Item:
There are no files associated with this item.
- RIS (EndNote)
- XLS (Excel)